115 related articles for article (PubMed ID: 11588375)
1. 3-Methyl 5-isopropyl 2-methoxyiminomethyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Vrábel V; Lehotay J; Oktavec D; Marchalín S
Acta Crystallogr C; 2001 Sep; 57(Pt 9):1073-4. PubMed ID: 11588375
[TBL] [Abstract][Full Text] [Related]
2. Two 1,4-dihydropyridine derivatives with potential calcium-channel antagonist activity.
Linden A; Safak C; Simşek R; Gündüz MG
Acta Crystallogr C; 2011 Feb; 67(Pt 2):o80-4. PubMed ID: 21285508
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-Methyl and (+/-)-ethyl 4-(2,3-difluorophenyl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate.
Linden A; Simşek R; Gündüz M; Safak C
Acta Crystallogr C; 2005 Dec; 61(Pt 12):o731-4. PubMed ID: 16330861
[TBL] [Abstract][Full Text] [Related]
5. Two carbamoyl-substituted dihydropyrimidines: potential mimics of dihydropyridine calcium channel blockers.
Ravikumar K; Sridhar B
Acta Crystallogr C; 2005 Jan; 61(Pt 1):o41-4. PubMed ID: 15640592
[TBL] [Abstract][Full Text] [Related]
6. Three methoxy-substituted diethyl 4-phenyl-2,6-dimethyl-1, 4-dihydropyridine-3,5-dicarboxylate compounds.
Metcalf SK; Holt EM
Acta Crystallogr C; 2000 Oct; 56 ( Pt 10)():1228-31. PubMed ID: 11025306
[TBL] [Abstract][Full Text] [Related]
7. Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.
Langs DA; Kwon YW; Strong PD; Triggle DJ
J Comput Aided Mol Des; 1991 Apr; 5(2):95-106. PubMed ID: 1651370
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
Fossheim R; Svarteng K; Mostad A; Rømming C; Shefter E; Triggle DJ
J Med Chem; 1982 Feb; 25(2):126-31. PubMed ID: 7057416
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thyroid hormone uptake by calcium antagonists of the dihydropyridine class.
Scholz GH; Vieweg S; Uhlig M; Thormann M; Klossek P; Goldmann S; Hofmann HJ
J Med Chem; 1997 May; 40(10):1530-8. PubMed ID: 9154974
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a novel series of 1,4-dihydropyridine analogues for larvicidal activity against Anopheles arabiensis.
Dharma Rao BD; Bhandary S; Chopra D; Venugopala KN; Gleiser RM; Kasumbwe K; Odhav B
Chem Biol Drug Des; 2017 Sep; 90(3):397-405. PubMed ID: 28135765
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
13. Cardioactivity and solid-state structure of two 4-isoxazolyldihydropyridines related to the 4-aryldihydropyridine calcium-channel blockers.
McKenna JI; Schlicksupp L; Natale NR; Willett RD; Maryanoff BE; Flaim SF
J Med Chem; 1988 Feb; 31(2):473-6. PubMed ID: 3339618
[TBL] [Abstract][Full Text] [Related]
14. Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators.
Rovnyak GC; Kimball SD; Beyer B; Cucinotta G; DiMarco JD; Gougoutas J; Hedberg A; Malley M; McCarthy JP; Zhang R
J Med Chem; 1995 Jan; 38(1):119-29. PubMed ID: 7837222
[TBL] [Abstract][Full Text] [Related]
15. Racemic isopropyl 1,4-dihydro-2,6-dimethyl-4-(6-methyl-2-pyridyl)-3- nitropyridine-5-carboxylate hemibenzene solvate.
Parrish JC; Shan R; Knaus EE; James MN
Acta Crystallogr C; 2000 Jan; 56 ( Pt 1)():107-9. PubMed ID: 10710689
[No Abstract] [Full Text] [Related]
16. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
17. Structure of the calcium channel antagonist, nimodipine.
Wang SD; Herbette LG; Rhodes DG
Acta Crystallogr C; 1989 Nov; 45 ( Pt 11)():1748-51. PubMed ID: 2610963
[TBL] [Abstract][Full Text] [Related]
18. Ethyl methyl 1,4-dihydro-4-(3-nitrophenyl)-2, 6-bis(1-piperidylmethyl)pyridine-3,5-dicarboxylate.
Duque J; Novoa De Armas H; Pomés Hernández R; Suárez Navarro M; Ochoa Rodríguez E; Salfrán E; Verdecia Reyes Y; Blaton NM; Peeters OM; De Ranter CJ
Acta Crystallogr C; 2000 Nov; 56 Pt 11():1346-7. PubMed ID: 11077293
[TBL] [Abstract][Full Text] [Related]
19. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
[TBL] [Abstract][Full Text] [Related]
20. Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.
Yamamoto T; Niwa S; Tokumasu M; Onishi T; Ohno S; Hagihara M; Koganei H; Fujita S; Takeda T; Saitou Y; Iwayama S; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2012 Jun; 22(11):3639-42. PubMed ID: 22560585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
